Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.5 (EPT/RI)-Apax Global Alpha Limited

13 Aug 2025 08:52

Form 8.5 (EPT/RI)-Apax Global Alpha Limited

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeApax Global Alpha Limited
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Apax Global Alpha Limited
(d) Date dealing undertaken:12th August 2025
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
OrdinaryPurchases227,279163.3162.6
OrdinarySales385,251163.4162.8

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:13th August 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91-9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
26th Mar 20201:12 pmRNSStatement regarding COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 20204:00 pmRNSDirector/PDMR Shareholding
17th Mar 20204:00 pmRNSDirector/PDMR Shareholding
13th Mar 202012:07 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 202012:07 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSNotice of Results
5th Mar 20202:17 pmRNSPurchase of Ordinary Shares under IM Agreement
5th Mar 20207:00 amRNSNotice of Investor Day
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSUpdated Key Information Document
3rd Mar 20207:00 amRNSNotice of AGM
3rd Mar 20207:00 amRNS2019 Annual Dividend
3rd Mar 20207:00 amRNS2019 Final Results
3rd Mar 20207:00 amRNS2019 Annual Report and Accounts
14th Feb 20207:00 amRNSDirector Change - Appointment
4th Feb 20207:00 amRNSApax Funds' Valuations as at 31 December 2019
15th Jan 20203:31 pmRNSPDMR Shareholding
15th Jan 20203:30 pmRNSPDMR Shareholding
26th Nov 20194:35 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSNotice of Annual Results
6th Nov 20197:00 amRNSQuarterly Results for 30 September 2019
16th Oct 20197:00 amRNSApax Funds' Valuations as at 30 September 2019
27th Sep 20194:40 pmRNSSecond Price Monitoring Extn
27th Sep 20194:35 pmRNSPrice Monitoring Extension
16th Sep 201910:37 amRNSNotice of Quarterly Results - September 2019
20th Aug 20199:17 amRNSPDMR Dealing - Share Transfers
14th Aug 20197:00 amRNS2019 Interim Dividend
14th Aug 20197:00 amRNS2019 Interim Results Highlights
14th Aug 20197:00 amRNS2019 Interim Report and Accounts
1st Aug 20197:00 amRNSApax Digital Fund Valuation as at 30 June 2019
30th Jul 20197:00 amRNSApax Funds' Valuations as at 30 June 2019
15th Jul 201910:59 amRNSProposed commitment to the Apax X Fund
22nd May 20197:00 amRNSAGA Investor Day
17th May 20194:30 pmRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSNotice of Interim Results - June 2019
8th May 201912:28 pmRNSResult of AGM Replacement
8th May 20197:00 amRNSQuarterly Results for 31 March 2019
7th May 20196:30 pmRNSResult of AGM
5th Apr 20195:32 pmRNSApax Funds' Valuations as at 31 March 2019
19th Mar 20192:39 pmRNSNotice of Investor Day
18th Mar 20199:59 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.